Zizi Elsisi

Zizi Elsisi

University of Washington

H-index: 3

North America-United States

About Zizi Elsisi

Zizi Elsisi, With an exceptional h-index of 3 and a recent h-index of 3 (since 2020), a distinguished researcher at University of Washington, specializes in the field of Health Outcomes, Health Economics, Health Policy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015–2019

Geographic disparity in the distribution of cancer clinical trials in the United States and the associated factors

Do future innovations in development influence oncologists’ treatment recommendations today? A survey of US oncologists.

How much does the us public value equity in health? A systematic review

HTA96 Applying Early Health Technology Assessments to Inform Novel Health Technology Innovation

EE284 Exploring the Value of a Novel Health Technology Tool to Support Diagnosis of Autism Spectrum Disorder

Medical and non-medical costs of sickle cell disease and treatments from a US perspective: a systematic review and landscape analysis

EE303 Estimating Recurrences Prevented and Costs Avoided with Atezolizumab in Early Non-Small Cell Lung Cancer in the United States

Zizi Elsisi Information

University

Position

___

Citations(all)

34

Citations(since 2020)

34

Cited By

0

hIndex(all)

3

hIndex(since 2020)

3

i10Index(all)

2

i10Index(since 2020)

2

Email

University Profile Page

Google Scholar

Zizi Elsisi Skills & Research Interests

Health Outcomes

Health Economics

Health Policy

Top articles of Zizi Elsisi

Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015–2019

Value in Health

2024/4/23

Geographic disparity in the distribution of cancer clinical trials in the United States and the associated factors

Journal of Managed Care & Specialty Pharmacy

2024/4

Zizi Elsisi
Zizi Elsisi

H-Index: 0

Meng Li
Meng Li

H-Index: 2

Do future innovations in development influence oncologists’ treatment recommendations today? A survey of US oncologists.

2023/6/1

How much does the us public value equity in health? A systematic review

2023/3/1

HTA96 Applying Early Health Technology Assessments to Inform Novel Health Technology Innovation

Value in Health

2023/6

Zizi Elsisi
Zizi Elsisi

H-Index: 0

EE284 Exploring the Value of a Novel Health Technology Tool to Support Diagnosis of Autism Spectrum Disorder

Value in Health

2023/6

Zizi Elsisi
Zizi Elsisi

H-Index: 0

Georgina Lynch
Georgina Lynch

H-Index: 4

Medical and non-medical costs of sickle cell disease and treatments from a US perspective: a systematic review and landscape analysis

2022/7

EE303 Estimating Recurrences Prevented and Costs Avoided with Atezolizumab in Early Non-Small Cell Lung Cancer in the United States

Value in Health

2022/7/1

Interventions to reduce fall-risk-increasing drug use to prevent falls: A narrative review of randomized trials

2021/4

Zizi Elsisi
Zizi Elsisi

H-Index: 0

Effectiveness of Deprescribing Interventions in Older Adults: An Overview of Systematic Reviews

2021

Expenditure, utilization, and cost of specialty drugs for multiple sclerosis in the US Medicaid population, 2008–2018

American health & drug benefits

2020/5

Zizi Elsisi
Zizi Elsisi

H-Index: 0

Ana L Hincapie
Ana L Hincapie

H-Index: 10

PRO52 EXPENDITURE, UTILIZATION, AND PRICE OF SPECIALTY DRUGS FOR MULTIPLE SCLEROSIS IN THE US MEDICAID POPULATION 2008-2018

Value in Health

2020/5/1

The Impact of Health Insurance Status on Healthcare Resource Utilization and Out-of-Pocket Costs in Patients with Multiple Sclerosis in the USA

2020

Zizi Elsisi
Zizi Elsisi

H-Index: 0

See List of Professors in Zizi Elsisi University(University of Washington)